Nevirapine (Viramune®)

DRUG2 trials

Sponsors

Boehringer Ingelheim

Conditions

Acquired Immunodeficiency SyndromeHealthy

Phase 1

Pharmacokinetic Properties of Two Dosages Nevirapine Extended Release (XR) Formulations Compared to VIRAMUNE® Tablet as Well as to Nevirapine XR Tablet in Healthy Male Volunteers

CompletedNCT02184312

Boehringer IngelheimHealthy

Start: 2008-04-30Updated: 2014-07-14

Unknown Phase

Clinical and Therapeutic Evaluation of the Infection by HIV/AIDS

CompletedNCT02191215

Boehringer IngelheimAcquired Immunodeficiency Syndrome

Start: 2003-06-30Updated: 2014-07-16